Article
Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.
Genes & development - 1 Aug 2004
Mao Jian-Hua, To Minh D, Perez-Losada Jesus, Wu Di, Del Rosario Reyno, Balmain Allan
Abstract excerpt
Pten heterozygous (Pten+/-) mice develop increased papilloma numbers and show decreased carcinoma latency time in comparison with controls after skin treatment with dimethyl benzanthracene (DMBA) and tetradecanoyl-phorbol acetate (TPA). H-ras mutation is normally a hallmark of DMBA-TPA-induced skin tumors, but 70% of carcinomas from Pten+/- mice do not exhibit this mutation, and in all cases have lost the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
